双成药业
(002693)
| 流通市值：20.71亿 | | | 总市值：21.00亿 |
| 流通股本：4.11亿 | | | 总股本：4.17亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 182,248,825.9 | 139,013,360.1 | 81,485,154.92 | 274,754,114.7 |
| 营业收入 | 182,248,825.9 | 139,013,360.1 | 81,485,154.92 | 274,754,114.7 |
| 二、营业总成本 | 213,053,392.18 | 150,367,222.37 | 84,923,954.21 | 329,188,619.07 |
| 营业成本 | 53,864,078.1 | 39,835,643.04 | 23,792,447.79 | 88,287,782.26 |
| 税金及附加 | 5,095,645.79 | 3,588,317.09 | 1,875,046.97 | 7,710,223.56 |
| 销售费用 | 80,597,603.34 | 61,023,157.21 | 37,202,576.52 | 126,201,822.08 |
| 管理费用 | 60,287,447.74 | 36,584,341.95 | 16,890,270.82 | 81,228,265.56 |
| 研发费用 | 5,967,831.34 | 4,461,499.59 | 2,589,268.35 | 14,594,023.13 |
| 财务费用 | 7,240,785.87 | 4,874,263.49 | 2,574,343.76 | 11,166,502.48 |
| 其中:利息费用 | 7,372,617.08 | 5,106,314.48 | 2,544,436.96 | 11,185,541.33 |
| 其中:利息收入 | 28,603.38 | 18,966.94 | 10,171.45 | 61,655.51 |
| 加:公允价值变动收益 | 141,510.6 | 1,097,474.9 | 1,577,219.53 | -56,175.77 |
| 加:投资收益 | 2,614,174.2 | 1,438,256.42 | 175,819.87 | 4,689,841.85 |
| 资产处置收益 | 467,606.24 | 475,181.39 | 475,296.02 | 29,914,310.91 |
| 资产减值损失(新) | 24,036.15 | 346.31 | - | -3,165,355.11 |
| 信用减值损失(新) | 172,596.81 | 213,206.76 | 146,717.24 | 93,296.1 |
| 其他收益 | 9,570,684.05 | 6,912,146 | 1,184,735.74 | 13,947,079 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -17,813,958.23 | -1,217,250.49 | 120,989.11 | -9,011,507.39 |
| 加:营业外收入 | 444,636.81 | 444,246.19 | 373.29 | 234,098.35 |
| 减:营业外支出 | 40,606.19 | 37,013.36 | 18,832.45 | 103,554.83 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -17,409,927.61 | -810,017.66 | 102,529.95 | -8,880,963.87 |
| 减:所得税费用 | 25,177.09 | 25,177.09 | -955.03 | -384,961.91 |
| 六、净利润 | -17,435,104.7 | -835,194.75 | 103,484.98 | -8,496,001.96 |
| 持续经营净利润 | -17,435,104.7 | -835,194.75 | 103,484.98 | -8,496,001.96 |
| 归属于母公司股东的净利润 | -1,620,567.41 | 8,790,256.43 | 4,505,619.82 | 9,012,396.69 |
| 少数股东损益 | -15,814,537.29 | -9,625,451.18 | -4,402,134.84 | -17,508,398.65 |
| (一)基本每股收益 | 0 | 0.02 | 0.01 | 0.02 |
| (二)稀释每股收益 | 0 | 0.02 | 0.01 | 0.02 |
| 八、其他综合收益 | 1,726.7 | 10,157.21 | 1,497.13 | 2,849.24 |
| 归属于母公司股东的其他综合收益 | 1,726.7 | 10,157.21 | 1,497.13 | 2,849.24 |
| 九、综合收益总额 | -17,433,378 | -825,037.54 | 104,982.11 | -8,493,152.72 |
| 归属于母公司股东的综合收益总额 | -1,618,840.71 | 8,800,413.64 | 4,507,116.95 | 9,015,245.93 |
| 归属于少数股东的综合收益总额 | -15,814,537.29 | -9,625,451.18 | -4,402,134.84 | -17,508,398.65 |
| 公告日期 | 2023-10-28 | 2023-08-31 | 2023-04-27 | 2023-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |